Delivery Order SPE2DB24D2018-SPE2DB24FWRL3
Award Date
2/12/24
Potential Completion Date
2/13/24
Potential Value
$5.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order worth $1,192.77 for the pharmaceutical product LINZESS 72 MCG CAPSULE UU 30S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 21, 2023. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,205.64 for the provision of LINZESS 145 MCG CAPSULE. The award was made by the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD), and has an ultimate completion date of February 2, 2022. The contract is a Firm Fixed Price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen is a major pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,758.28 firm fixed-price delivery order is for the pharmaceutical product LINZESS 145 MCG CAPSULE UU 30S. The contract has a period of performance through February 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as the primary vehicle for the...
This federal contract award, valued at $2,653.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order for the pharmaceutical product LINZESS 290 MCG CAPSULE UU 30S, with a period of performance through December 6, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly within the military and veterans' healthcare...
This federal contract award is a delivery order with a ceiling value of $3,447.03, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LINZESS 145 MCG CAPSULE pharmaceutical product and has a completion date of May 19, 2023. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a...
This federal contract award from the Defense Logistics Agency (DLA) was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,411.52 firm-fixed-price delivery order is for the supply of LINZESS 290 MCG capsules. The contract has an ultimate completion date of February 1, 2024. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which has a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $8,069.09 firm fixed-price delivery order contract is for the supply of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC enables the efficient...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Linzess 290 MCG capsules. The $7,821.77 contract is a firm fixed-price delivery order with a completion date of March 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
This federal contract award, valued at $3,237.99, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product, with an ultimate completion date of April 11, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., involves the delivery of LINZESS 72 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract has a ceiling value of $2,674.11 and a completion date of September 21, 2023. This award is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...